Leger, P., Chirwa, S., Turner, M., Richardson, D. M., Baker, P., Leonard, M., . . . Haas, D. W. (2016). Pharmacogenetics of Efavirenz Discontinuation for Reported Central Nervous System Symptoms Appears to Differ by Race. Pharmacogenet Genomics.

Leger, Paul, Sanika Chirwa, Megan Turner, Danielle M. Richardson, Paxton Baker, Michael Leonard, Husamettin Erdem, Lana Olson, e David W. Haas. "Pharmacogenetics of Efavirenz Discontinuation for Reported Central Nervous System Symptoms Appears to Differ By Race." Pharmacogenet Genomics 2016.

Leger, Paul, et al. "Pharmacogenetics of Efavirenz Discontinuation for Reported Central Nervous System Symptoms Appears to Differ By Race." Pharmacogenet Genomics 2016.